Annual Gross Profit
$346.24 M
+$166.43 M+92.56%
31 December 2023
Summary:
Catalyst Pharmaceuticals annual gross profit is currently $346.24 million, with the most recent change of +$166.43 million (+92.56%) on 31 December 2023. During the last 3 years, it has risen by +$244.20 million (+239.33%). CPRX annual gross profit is now at all-time high.CPRX Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$109.42 M
+$2.11 M+1.97%
30 September 2024
Summary:
Catalyst Pharmaceuticals quarterly gross profit is currently $109.42 million, with the most recent change of +$2.11 million (+1.97%) on 30 September 2024. Over the past year, it has increased by +$20.90 million (+23.61%). CPRX quarterly gross profit is now at all-time high.CPRX Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$397.47 M
+$20.90 M+5.55%
30 September 2024
Summary:
Catalyst Pharmaceuticals TTM gross profit is currently $397.47 million, with the most recent change of +$20.90 million (+5.55%) on 30 September 2024. Over the past year, it has increased by +$96.43 million (+32.03%). CPRX TTM gross profit is now at all-time high.CPRX TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPRX Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +92.6% | +23.6% | +32.0% |
| 3 y3 years | +239.3% | +257.1% | +248.3% |
| 5 y5 years | +10000.0% | +312.7% | +537.8% |
CPRX Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +239.3% | at high | +257.1% | at high | +248.3% |
| 5 y | 5 years | at high | >+9999.0% | at high | +337.9% | at high | +537.8% |
| alltime | all time | at high | at high | at high |
Catalyst Pharmaceuticals Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $109.42 M(+2.0%) | $397.47 M(+5.5%) |
| June 2024 | - | $107.31 M(+24.8%) | $376.57 M(+5.5%) |
| Mar 2024 | - | $85.99 M(-9.3%) | $356.81 M(+3.1%) |
| Dec 2023 | $346.24 M(+92.6%) | $94.76 M(+7.0%) | $346.24 M(+15.0%) |
| Sept 2023 | - | $88.52 M(+1.1%) | $301.04 M(+15.7%) |
| June 2023 | - | $87.54 M(+16.1%) | $260.10 M(+19.3%) |
| Mar 2023 | - | $75.42 M(+52.2%) | $218.03 M(+21.3%) |
| Dec 2022 | $179.81 M(+51.2%) | $49.56 M(+4.2%) | $179.81 M(+11.5%) |
| Sept 2022 | - | $47.58 M(+4.6%) | $161.21 M(+11.7%) |
| June 2022 | - | $45.47 M(+22.2%) | $144.27 M(+10.4%) |
| Mar 2022 | - | $37.20 M(+20.1%) | $130.62 M(+9.8%) |
| Dec 2021 | $118.95 M(+16.6%) | $30.96 M(+1.0%) | $118.95 M(+4.2%) |
| Sept 2021 | - | $30.64 M(-3.7%) | $114.13 M(+4.8%) |
| June 2021 | - | $31.82 M(+24.7%) | $108.93 M(+6.2%) |
| Mar 2021 | - | $25.52 M(-2.4%) | $102.57 M(+0.5%) |
| Dec 2020 | $102.03 M(+16.5%) | $26.15 M(+2.8%) | $102.03 M(+0.4%) |
| Sept 2020 | - | $25.44 M(-0.1%) | $101.61 M(-1.0%) |
| June 2020 | - | $25.46 M(+1.9%) | $102.69 M(+0.9%) |
| Mar 2020 | - | $24.99 M(-2.9%) | $101.80 M(+16.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $87.55 M(>+9900.0%) | $25.72 M(-3.0%) | $87.55 M(+40.5%) |
| Sept 2019 | - | $26.51 M(+7.9%) | $62.32 M(+74.0%) |
| June 2019 | - | $24.58 M(+128.9%) | $35.81 M(+218.7%) |
| Mar 2019 | - | $10.74 M(+2047.3%) | $11.24 M(+2147.3%) |
| Dec 2018 | $500.00 K(>+9900.0%) | $500.00 K(>+9900.0%) | $500.00 K(>+9900.0%) |
| Sept 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2009 | - | $0.00 | $0.00 |
| Dec 2008 | $0.00(0.0%) | - | - |
| Dec 2002 | $0.00 | - | - |
FAQ
- What is Catalyst Pharmaceuticals annual gross profit?
- What is the all time high annual gross profit for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual gross profit year-on-year change?
- What is Catalyst Pharmaceuticals quarterly gross profit?
- What is the all time high quarterly gross profit for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly gross profit year-on-year change?
- What is Catalyst Pharmaceuticals TTM gross profit?
- What is the all time high TTM gross profit for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals TTM gross profit year-on-year change?
What is Catalyst Pharmaceuticals annual gross profit?
The current annual gross profit of CPRX is $346.24 M
What is the all time high annual gross profit for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual gross profit is $346.24 M
What is Catalyst Pharmaceuticals annual gross profit year-on-year change?
Over the past year, CPRX annual gross profit has changed by +$166.43 M (+92.56%)
What is Catalyst Pharmaceuticals quarterly gross profit?
The current quarterly gross profit of CPRX is $109.42 M
What is the all time high quarterly gross profit for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly gross profit is $109.42 M
What is Catalyst Pharmaceuticals quarterly gross profit year-on-year change?
Over the past year, CPRX quarterly gross profit has changed by +$20.90 M (+23.61%)
What is Catalyst Pharmaceuticals TTM gross profit?
The current TTM gross profit of CPRX is $397.47 M
What is the all time high TTM gross profit for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high TTM gross profit is $397.47 M
What is Catalyst Pharmaceuticals TTM gross profit year-on-year change?
Over the past year, CPRX TTM gross profit has changed by +$96.43 M (+32.03%)